medicine Product List and Ranking from 36 Manufacturers, Suppliers and Companies | IPROS GMS

Last Updated：Jul 29, 2026 Aggregation Period:Jul 01, 2026～Jul 28, 2026
This ranking is based on the number of page views on our site.

medicine Manufacturer, Suppliers and Company Rankings

Last Updated：Jul 29, 2026 Aggregation Period:Jul 01, 2026～Jul 28, 2026
This ranking is based on the number of page views on our site.

マーケットリサーチセンター Tokyo//Service Industry
恵命堂 Tokyo//Pharmaceuticals and Biotechnology
ケーナインラボ Tokyo//Testing, Analysis and Measurement
4 null/null
5 東和製薬本社 Wakayama//others

Go to Company Ranking

medicine Product ranking

Last Updated：Jul 29, 2026 Aggregation Period:Jul 01, 2026～Jul 28, 2026
This ranking is based on the number of page views on our site.

Useful Information: The History of Gajutsu 恵命堂
K9 Lab Inc. Company Profile ケーナインラボ
Toho Pharmaceutical Co., Ltd. Business Introduction 東和製薬本社
4 Sogo Pharmaceutical Co., Ltd. Company Profile 相互薬工
4 Clinical Trial: Achondroplasia リボミック

medicine Product List

151～156 item / All 156 items

Displayed results

[Market Report] Global Market for Skin Cancer Treatment

The global market for skin cancer treatment is rapidly expanding and is expected to reach 14.5 billion USD by 2031.

As the battle against skin cancer, one of the most common cancers, continues, the global skin cancer treatment market is emerging as a bastion of hope. This market recorded a solid revenue of approximately 7.72 billion USD in 2022 and is expected to achieve a compound annual growth rate (CAGR) of 7.3% during the forecast period from 2023 to 2031, indicating remarkable growth. By 2031, it is projected to reach an astonishing valuation of 14.5 billion USD. Skin cancer is often caused by excessive sunbathing and ultraviolet rays, and there is growing global concern about it. The rising incidence of skin cancer and increasing awareness of the importance of early diagnosis and treatment are driving demand for advanced and effective skin cancer treatment options. For application methods, please check the [PDF download] button or apply directly through the related links.

Company：Panorama Data Insights Ltd.
Price：Other

others
medicine

View product details

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Market Report] The Global Market for Oral Ulcer Treatment

The global market for oral mucositis treatment is projected to reach 1.92 billion dollars by 2031.

The global oral ulcer treatment market, which achieved sales of 1.34 billion USD in 2022, is steadily growing and is projected to reach 1.92 billion USD by 2031. This growth is progressing at a compound annual growth rate (CAGR) of 4.1% from 2023 to 2031, reflecting the increasing demand for effective treatments for this common oral condition. Oral ulcers are characterized by painful sores or lesions on the oral mucosa, significantly impacting an individual's quality of life (QOL). These ulcers can appear on the cheeks, lips, tongue, gums, the roof and floor of the mouth, and sometimes even the esophagus. Generally, oral ulcers present as lesions with a red outer ring and a pale or yellow center, causing discomfort or pain, especially during eating and drinking. For application methods, please check the [PDF download] button or apply directly through the related links.

Company：Panorama Data Insights Ltd.
Price：Other

others
medicine

View product details

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Market Report] Global CAR-T Cell Therapy Market

Global CAR-T Cell Therapy Market: A Pioneer in the Fight Against Cancer, Expected to Reach 5.9 Billion USD by 2031

The global CAR T cell therapy market is at the forefront of the fight against cancer, providing innovative and promising treatment options for patients. According to recent market reports, the global CAR T cell therapy market generated approximately $1.9 billion in revenue in 2022, and it is estimated to surge to $5.9 billion by 2031. This remarkable growth trajectory is projected to have a steady annual compound growth rate (CAGR) of 13.5% from 2023 to 2031. Chimeric Antigen Receptor (CAR) T cell therapy is a groundbreaking form of gene cell therapy that utilizes the body's T cells to target and eliminate cancer cells. Typically, the treatment involves three key steps: genetic modification of T cells, infusion of CAR T cells into the patient's body, and collection of T cells, all working together to combat cancer. You can check the application method by clicking the [PDF Download] button or apply directly through the related links.

Company：Panorama Data Insights Ltd.
Price：Other

others
medicine

View product details

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Market Report] Global Inflammatory Bowel Disease Treatment Market

The global inflammatory bowel disease treatment market is expected to achieve steady growth, reaching 34 billion USD by 2031.

The global inflammatory bowel disease (IBD) treatment market is on an upward trajectory, with revenues reaching approximately $22 billion in 2022, and an estimated value of $34 billion by 2031. This significant growth is projected to occur at a compound annual growth rate (CAGR) of 5.1% during the forecast period from 2023 to 2031. Inflammatory bowel disease (IBD) is a chronic condition characterized by inflammation of the gastrointestinal tract. It primarily consists of two distinct conditions: Crohn's disease and ulcerative colitis. Crohn's disease is known for causing inflammation and discomfort in various parts of the gastrointestinal tract, often affecting the small intestine and the upper part of the large intestine. On the other hand, ulcerative colitis primarily causes pain and inflammation in the colon. You can check the application method by clicking the [PDF Download] button or apply directly through the related links.

Company：Panorama Data Insights Ltd.
Price：Other

others
medicine

View product details

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Market Report] Global Schizophrenia Treatment Drug Market

The global schizophrenia treatment market is expected to reach 12.57 billion USD by 2031, aiming for steady growth.

The global schizophrenia treatment market is experiencing steady growth, with total revenue reaching approximately $7.57 billion in 2022. Furthermore, it is estimated to rise to $12.57 billion by 2031, corresponding to a compound annual growth rate (CAGR) of 5.8% from 2020. The forecast period is from 2023 to 2031. Schizophrenia is characterized by its chronic and severe nature, significantly impacting an individual's behavior, thinking, perception of reality, emotional expression, and interpersonal relationships. Although schizophrenia is not as common as other severe mental disorders, it remains one of the most persistent and debilitating mental illnesses. You can check the application method by clicking the [PDF Download] button or apply directly through the related links.

Company：Panorama Data Insights Ltd.
Price：Other

others
medicine

View product details

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Market Report] Global Pruritus Treatment Market

The global market for pruritus treatment drugs is expected to expand significantly, reaching 11.1 billion USD by 2031.

The global market for pruritus treatment drugs reached approximately 8.1 billion USD in revenue in 2022 and is poised for significant growth. Recent market analysis predicts that the pruritus treatment drug market will expand at a stable annual average growth rate (CAGR) of 3.6%. During the forecast period from 2023 to 2031, it is expected to exceed 11.1 billion USD by 2031. The global pruritus treatment drug market is anticipated to expand significantly in the foreseeable future due to advancements in medical research, increasing healthcare awareness, and a rising demand for symptom management solutions. As pharmaceutical companies continue to invest in the development of innovative treatments, the market is expected to achieve sustained growth, providing hope to millions of people suffering from pruritus worldwide. For application methods, please check the [PDF download] button or apply directly through the related links.